Dan interviews Leland Garrahan, VP at MedEquity Capital Ep.802
Random Musings From The Clinical Trials Guru
00:00
Navigating Investments in Clinical Trial Sites and Healthcare Dynamics
The chapter delves into the current trend of acquisitions in clinical trial sites by site networks and hospital systems, predicting a potential cooling off period in private equity investments post-COVID. It explores the motivations of business owners considering investment options, emphasizing the importance of ownership retention and post-acquisition incentives. The conversation also highlights the complexities of deal valuation, the investment sweet spot in clinical trial sites, and the correlation between healthcare dynamics and clinical research from an investor perspective.
Transcript
Play full episode
